CRA experts advised counsel and presented before the FTC on transactions involving Novartis’ acquisition of cancer drugs from GlaxoSmithKline, GSK’s joint venture with Novartis on consumer health, and Novartis’s sale of Novartis Animal Health to Eli Lilly & Co. The deals ultimately went forward with certain divestitures.
“Suite dreams”: Market definition and complementarity in the digital age
Certain products exhibit such strong complementarities that they should not be evaluated separately. For example, consider a pair of shoes or the various...